Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

338

HTML

2910

Figures (1-1)

231

Tables (1-7)

213

Sum=3692

Nov 14, 2005 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Nov 14, 2005; 11(42): 6607-6612
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6607

Table 3 Comparison of the result of different tumor markers between HCC and non-HCC group

¹All PIVKA-II (+) HCC patients are AFP (+).

²One KL-6 (+) HCC patient is AFP (–).

Citation: Gad A, Tanaka E, Matsumoto A, Wahab MAE, Serwah AEH, Attia F, Ali K, Hassouba H, el-Deeb AER, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(42): 6607-6612
URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6607.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6607